A draft report, with comments due November 13
The Maryland Insurance Administration and Department of Health presented the draft final report at the October 30 PBM workgroup meeting. Meeting slides accept written comments through the end of Friday, November 13, at pharmacyservicesworkgroup.mia@maryland.gov. The recommendations remain draft policy proposals.12
The draft recommends a funded external assessment of pharmacy-benefit delivery models. It also proposes revised specialty-drug and accredited specialty-pharmacy definitions, public specialty-drug lists and updates, and further payment-data collection. The specialty-drug proposal would remove a category allowing health plans to make the designation themselves.3
The detailed recommendations identify access for qualified in-network specialty pharmacies as an additional consideration. They do not establish a new reimbursement floor. The agencies make no formal recommendation on ERISA exemptions, citing ongoing litigation.3
What pharmacy leaders can address
Chad’s analysis: Comments should explain where specialty designations prevent a capable pharmacy from dispensing and what accreditation requirements would add to access or cost. Distinguish a request for broader network participation from a reimbursement proposal. The draft’s executive summary describes in-network access more firmly than its detailed discussion; stakeholders can ask the agencies to make that recommendation precise before finalizing the report.3
Source notes
- Md. Ins. Admin., Pharmacy Benefits Managers Workgroup Meeting Dates, Meeting Six: Oct. 30, 2026 (last visited Nov. 2, 2026).
- Md. Ins. Admin. & Md. Dep’t of Health, Pharmacy Benefits Managers Workgroup Meeting #6, at 8 (Oct. 30, 2026).
- Md. Ins. Admin. & Md. Dep’t of Health, Workgroup to Study Pharmacy Benefits Managers: Draft Final Report 1, 11–14 (draft presented Oct. 30, 2026).